1. Home
  2. NVMI vs BMRN Comparison

NVMI vs BMRN Comparison

Compare NVMI & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nova Ltd.

NVMI

Nova Ltd.

N/A

Current Price

$420.60

Market Cap

12.6B

Sector

Technology

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$66.64

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVMI
BMRN
Founded
1993
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
11.4B
IPO Year
2001
1999

Fundamental Metrics

Financial Performance
Metric
NVMI
BMRN
Price
$420.60
$66.64
Analyst Decision
Strong Buy
Buy
Analyst Count
8
18
Target Price
$431.88
$88.22
AVG Volume (30 Days)
504.5K
2.2M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.77
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$20.94
$15.02
Revenue Next Year
$19.53
$12.23
P/E Ratio
$56.79
$87.48
Revenue Growth
N/A
17.62
52 Week Low
$232.73
$49.26
52 Week High
$615.99
$70.98

Technical Indicators

Market Signals
Indicator
NVMI
BMRN
Relative Strength Index (RSI) 50.45 64.94
Support Level $416.61 $58.03
Resistance Level $483.15 N/A
Average True Range (ATR) 20.53 2.04
MACD 6.42 0.54
Stochastic Oscillator 97.28 67.91

Price Performance

Historical Comparison
NVMI
BMRN

About NVMI Nova Ltd.

Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: